Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.91 -0.04 (-2.05%)
As of: Nov 12, 2026 · 9:30 AM EST

Polaryx Therapeutics (PLYX) Income towards Parent Company (2025 - 2026)

Updated

Polaryx Therapeutics (PLYX) recorded Income towards Parent Company of -$1.4 million in Q2 2026, compared with -$1.01 million a year earlier.

Analysis

Polaryx Therapeutics (PLYX) Income towards Parent Company (2025 - 2026) Analysis & Trends

On a TTM basis, Polaryx Therapeutics' Income towards Parent Company came in at -$10.05 million as of Jun 30, 2026; for FY2025, it came in at -$9 million.

  • Across earlier years, Income towards Parent Company came in at -$30.4 million in FY2024.
  • Quarterly Income towards Parent Company has ranged from -$5.1 million in Q1 2025 to -$1.01 million in Q2 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Polaryx Therapeutics 93.21 Mn 68.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.40 Mn
Mar 31, 2026 -2.54 Mn
Jun 30, 2025 -1.01 Mn
Mar 31, 2025 -5.10 Mn
API Access

Polaryx Therapeutics Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PLYX&period=max&api_key=YOUR_API_KEY